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Abstract.  Glucocorticoids and hepatocyte-sth'nulating 
factor (HSF; a monocyte/macrophage-derived  polypep- 
tide) are potent regulators of fibrinogen biosynthesis. 
Using primary rat hepatocytes and a rat hepatoma cell 
line (FAZA) we have determined, more precisely, the 
interaction between these two molecules in the control 
of fibrinogen production. When dexamethasone (DEX) 
or HSF is added to the cells, there is a substantial in- 
crease in fibrinogen production 0.5-3-fold).  However, 
if both agents are administered simultaneously the re- 
sponse is much greater with a  15-20-fold rise in syn- 
thesis. Quantitative RNA analysis demonstrates that 
when the factors are present individually only HSF 
elevates fibrinogen mRNA levels, but the effect is 
much enhanced in the presence of DEX.  This pattern 
is also seen in the results of the in vitro transcription 
assays which allow quantitation of mRNA synthesis in 
isolated nuclei. Cycloheximide does not significantly 
interfere with the increased transcription brought about 
by HSF in either cell type. However, the DEX en- 
hancement is blocked by cycloheximide in FAZA cells, 
thus indicating that in the transformed cell protein syn- 
thesis is required for maximal transcription to occur. 
Data presented here demonstrates the requirement for 
two types of regulator molecules in the control of 
fibrinogen gene expression; a polypeptide hormone 
(HSF) that increases transcription and a steroid (DEX) 
that enhances the action of the polypeptide. 
O 
ER the past few years considerable interest has fo- 
cused on the biosynthesis of fibrinogen. In part this 
has been due to the unique molecular  arrangement  of 
the protein. The functional molecule is composed of three 
pairs of nonidentical polypeptides bound together through 
complex sets of disulfide bridges.  Each fibrinogen subunit 
(Act, BI3, and ?) is encoded by separate, but closely linked, 
genes (located in chromosome  4 in man and 2 in rat) that are 
regulated as a stringently coordinated family (12, 13,  I9). 
Recently we reported that all three fibrinogen mRNAs in- 
crease simultaneously and to the same extent when hepato- 
cytes are incubated in the presence of  hepatocyte-stimulating 
factor (HSF), 1 a  polypeptide  which is derived from acti- 
vated peripheral blood monocytes and certain myelogenous 
tumor lines (9, 24). Certain glucocorticoids have also been 
shown to stimulate  fibrinogen  synthesis  in hepatocyte cul- 
tures (23). During an acute inflammatory  challenge the con- 
centration of  adrenal glucocorticeids  are markedly  increased 
in the intact animal (20). The levels of  several hepatically  de- 
rived plasma proteins are substantially altered during acute 
inflammation ostensibly in response to greater concentra- 
tions of glucocorticoids (14, 15). Glucocorticoids have also 
been implicated in elevating fibrinogen mRNA levels in the 
liver (5, 22), but little information has been published detail- 
ing  the mechanism(s) through which they elicit this  re- 
sponse. 
1. Abbreviations used in thispaper: CHX, cycloheximide; DEX, dexameth- 
asone;  HSF, hepatocyte-stimulating  factor. 
In this study, we partitioned out the role that is played by 
HSF and glucocorticoids in the control of  fibrinogen biosyn- 
thesis. We provide evidence that although  HSF and gluco- 
corticoids by themselves increase fibrinogen secretion (and 
cytoplasmic  mRNA levels in the case ofHSF), a much great- 
er elevation in fibrinogen production occurs when both are 
present. Nuclear run-off  experiments reveal that HSF stimu- 
lates transcription  whereas glucocorticoids themselves did 
not. However, both factors are required for maximum tran- 
scription.  These findings provide strong evidence that HSF 
is a transcriptional  regulator of  the fibrinogen genes and that 
the glucocorticoid enhancement of transcription  is exerted 
through  a mechanism which involves protein synthesis. 
Materials and Methods 
Cell Culture 
Primary  hepa~ytes were prepared from 200-300-g Sprague-Dawley  rats 
using the collagenase perfusion  procedure described  by Segten (28) with 
several modifications (23). Confluent monolayers were prepared by plating 
0.5 ml of a washed hepatocyte suspension (6.0  x  106 colls/ml) on 35-ram 
tissue culture plates precoated with fibron~-tin (100 gg/rrd) in sterile PBS. 
The medium was changed after 1 h and the attached cells were allowed to 
spread overnight. Hepatocytes were cultured in Williams' Medium E lacking 
arginine,  but supplemented with ornithine  (100 eM), heparin  (3.5 U/aft), 
insulin  (20 mU/ml), penicillin G  (100 U/ml), streptomycin  sulfate (200 
gg/ml), gentamy:in (60 ttg/ml), and FBS (5% vol/vol). To remove gluco- 
corticoids, the serum was extracted with activated charcoal as described by 
Dobner et al. (7). FAZA cells, from a Ruber-derived rat hepatoma cell line, 
were grown to confluency on Falcon 35-ram tissue culture plates (17). The 
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lin G (100 U/re.l), streptomycin sulfate (200 I.tg/ml), gentamycin (60 llg/ml), 
and FBS (10% vol/vol).  The cells were changed to medium containing 
glucocorticoid-free  serum 48 h before treatment. 
Monocyte-conditioned  Medium 
Human buff3' coats were obtained from the American Red Cross through 
anonymous donors.  The monocytes  were purified as described previously 
(9). Calls were plated on 60-mm tissue culture plates at a density of 3  x 
l0  T ceUs/ml.  The  monocytes  were  incubated  for  24  h  in  serum-free 
McCoy's  5A medium in 5% COz/95%  air.  The conditioned medium was 
harvested from the cells after 24 h and served as the source of HSE 
Immunoassays 
Rat fibrinogen antibody was produced in goats and made monospecific by 
affinity chromatography  using flbrinogan covalently coupled to Sepharose 
(6). Fibrinogen  concentrations in hepatocyte and hepatoma media were de- 
termined using a quantitative ELISA as previously  described (16). 
Quantitation of  mRNA 
After the removal of media from confluent monolayers of either primary he- 
patocytes or hepatoma cells,  they were washed three times with ice cold 
PBS.  Subsequently  the washed cells were scraped and homogenized into 
4 M guanidine thiocynate  lysis buffer as described by Chirwin et al. (4). 
The homogenate was then nfixed  1:1 vol/vol with a solution of 20x  SSC 
(Ix SSC contains 0.15 M NaCl, 15 mM trisodium citrate) and 37% formal- 
dehyde in a 3:2 ratio, and heated to 65~  for 15 rain. This mixture was cen- 
trifuged to remove insoluble cell debris, and the supernatants  were then 
diluted with 20x SSC and blotted onto nitrocellulose using the slot blot ap- 
paratus (Schleicher & Sehuell, Inc., Keene,  Nil).  100 ng of cytoplasmic 
RNA was applied to each slot.  A standard dilution of each sample was car- 
ried out for each of six different experiments performed. After baking, the 
filters were prehybridized in 5￿  Denhardt's solution, 4x SSC, 0.1% SDS, 
and 100 txg/ml sonicated salmon sperm DNA for 2--4 h at 42~  Hybridiza- 
tion was carried out using rat fibrinogen eDNA labeled with 32p by nick 
translation using [32p]dC'l'P (3,000 Ci/mM; Amersham Corp.,  Arlington 
Heights,  IL) (18). The specific activity of each probe was 108 cpm/Izg. The 
filter was washed extensively  before autoradiography. 
RNA Analysis by Northern Blots 
RNA extracted by hot phenol method (26) was subjected to electrophoresis 
on a 1.5% agarose gel in the presence of 6% formaldehyde, then transferred 
to nitrocellulose filters. The immobilized RNA was prehybridized  and hy- 
bridized as described above. 
Blocking of  Protein Synthesis by Cycloheximide (CHX) 
2.0 I~g/ml  (final concentration)  CHX (Sigma Chemical Co,, St. Louis, MO) 
was added to confluent monolayers of either primary hepatoeytes or hepa- 
toma ceils 2 h before the addition of HSF and/or dexamethasone (DEX). 
Pilot studies revealed that when [35S]methionine (20 ttCifml) was added to 
the cells after a 2-h incubation  with CHX greater than  90 % of the incorpora- 
tion of the labeled amino acid into TCA-precipitable counts were inhibited 
in both cell types  (data not shown). 
In Vitro Nuclear Transcription  Assays 
Nuclei were prepared from rat hepatocytes  and FAZA cells essentially as 
described by Schibler et al.  (27).  1.0-5.0  x  l0  s cells were scraped into 
PBS, washed,  homogenized, and the nuclei sedimanted through a sucrose 
cushion.  The  RNA  elongation  reaction  was  carried  out  according to 
Gariglio et al. (10). Briefly, 2  x  107 nuclei were incubated for 10 min at 
26~  in a 200-ml reaction mixture containing 100 mM Tris-Cl  (pH 7.9); 
50 mM NaCI;  4 mM MnCI2; 1.2 mM dithiothreitol (DTT);  0.1 mM phe- 
nylmethylsulfonyl fluoride (PMSF); 0.4 mM EDTA; 1.0 mM GTP, ATE and 
CTP; 29% glycerol;  1t3 mM pbosphecreatine; 5 ItM UTP; 150 U/mi RNA- 
sin; and 0.2 mCi [uP]UTP (650 Ci/mmol from ICN K&K Laboratories 
Inc., Plainview, NY). The RNA was isolated as described by Groudine et 
al. (11). The reaction was terminated with DNase I and the protein digested 
with proteinase K in the presence of SDS. The mixture was phenol/chloro- 
form-extracted and then precipitated with TCA. The DNase I and proteinase 
digestions were repeated  and were followed by two phenol/chloroform ex- 
tractions and finally two chloroform extractions.  The RNA was precipitated 
with ethanol and collected by cantrifugation. Approximately  3.0  x  los 
epm were recovered in this manner and allowed to hybridize for 3 d at 42~ 
to the nitrocellulose-bound linearized plasmids containing the fibrinogen 
and AT-ffl eDNA inserts.  The filters were then washed four times for 15 
rain at room temperature in Ix  SSPE (20x  SSPE contains 3.6 M NaCI; 
200 mM NaH2PO4, pH 7.4, and 20 mM Na2EDTA), 0.1% SDS, and twice 
for 30 rain at 52~  in 0.Ix SSPE, 0.1% SDS and allowed to air dry before 
autoradiography. The results reported represent the typical finding  observed 
from nuclear runoff experiment using four different preparations of hepato- 
cyte nuclei. 
Results 
Effect of  DEX and HSF on l~brinogen Secretion 
Two different cell types were used to assess the effect of DEX 
and  HSF  on  fibrinogen  production.  Primary  hepatocytes 
were used since their response to HSF has been well docu- 
mented (23). We have previously suggested that a glucocorti- 
coid was a necessary additive for maintaining primary hepa- 
tocytes in culture (23).  More recent studies, however (data 
not shown), indicated that glucocorticoids are not absolutely 
required for cellular maintenance during an incubation period 
of 24-48 h. It was therefore possible to partition out the role 
played by the glucocorticoid and the HSF in primary hepato- 
cytes. We have also shown that FAZA cells synthesize and 
secrete fibrinogen (21). These cells grow indefinitely in the 
absence of glucocorticoids and therefore they not only serve 
as a suitable control cell system, but also provide information 
on the responsiveness of a tumor cell line to the HSF mol- 
ecule. 
A  dose-response  relationship  between  the  secretion  of 
fibrinogen and the concentration of  DEX in the two cell types 
is shown in Fig. 1. The primary hepatocyte increased its syn- 
thesis  and  secretion  1.5-fold  at  10  -7 M  DEX.  The  FAZA 
cell response was considerably greater,  ~3.5-fold, although 
the actual amount of fibrinogen being made by the hepato- 
cytes  was  higher  than  the  transformed  cells;  1.0--1.5 ~tg 
fibrinogen/mg cell protein/24 h vs. 0.1-0.2 I~g fibrinogen/mg 
cell protein/24 h. 
The response of primary hepatocytes to increasing concen- 
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Figure 1. Dependence of fibrinogen secretion on the concentration 
of DEX.  Primary  hepatocytes  and  FAZA ceils  were  plated,  or 
grown, to confluency in the absence of glucocorticoids.  DEX was 
added to the medium at the concentrations indicated. After 24 h, 
the  medium  was  harvested  and assayed  for  fibrinogen using  an 
ELISA. 
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Figure 2.  Dependence  of fi- 
brinogen secretion on the con- 
centration of HSF in the pres- 
ence or absence of DEX. (A) 
Primary hepatocytes  were pre- 
pared in medium lacking glu- 
cocorticoids  and  allowed to 
spread to form confluent  mono- 
layers on 35-mm tissue  cul- 
ture plates. The medium was 
changed and HSF added at the 
concentrations  indicated  ei- 
ther in the presence (o) or ab- 
sence  (e)  of  10  -7  M  DEX. 
The cells were incubated for 
24 h, then the medium was as- 
sayed for fibrinogen and the 
total cell protein determined. 
(B) Similar experiment ~vith 
FAZA cells which were grown 
to  confluency in  glucocorti- 
coid-free medium. The values 
given represent the mean SEM 
of three replicates from a sin- 
gle experiment. 
trations of HSF in the presence and absence of the synthetic 
glucocorticoid, DEX, is shown in Fig. 2 A. Primary rat he- 
patocytes were prepared as described above in medium lack- 
ing glucocorticoids. A maximum response to HSF occurred 
at 20 U/ml when DEX was present in the medium at a con- 
centration of 100 nM. (A unit of HSF activity is that amount 
of HSF required for a half-maximal fibrinogen synthesis re- 
sponse in primary hepatocytes; 23, 25). In its absence, there 
was only a 2.5-fold increase in fibrinogen production over 
controls during the 24-h incubation period. The FAZA cells 
showed the same qualitative response to HSF as did the pri- 
mary hepatocytes (Fig. 2 b).  One consistent difference be- 
tween the two cell types is that the FAZA cells require con- 
siderably greater concentration of HSF (3-5X) than do the 
primary hepatocytes to get maximal fibrinogen synthesis. 
Effect of  Different Steroids on Fibrinogen Production 
We tested a number of different steroids on primary hepato- 
cytes in the presence and absence of HSF to determine if 
steroids  belonging  to  the  androgen,  estrogen,  or  miner- 
alocorticoid groups could also interact with HSF to affect 
fibrinogen production.  Fig.  3  shows the results of studies 
using  seven different steroids.  Only those  steroids  in  the 
glucocorticoid family (hydrocortisone, corticosterone, and 
DEX) enhanced fibrinogen biosynthesis. There was a slight 
but signifcant increase with aldosterone reflecting, in part, 
its known glucocorticoid activity (2). 
Effect of  DEX and HSF on Fibrinogen mRNA 
Levels in the Presence and Absence of CHX 
Cytodot Analysis.  In a previous study we demonstrated by 
cytodot hybridization that HSF (in the presence of DEX) ele- 
vates the cytoplasmic levels of fibrinogen mRNAs  20-fold 
(9). Here we performed similar experiments, but under con- 
ditions in which each modulator was added individually as 
well as together. The results shown in Fig. 4  a  (A and B) 
demonstrate that  in  primary  hepatocytes and  FAZA  cells 
maximal mRNA increases occur only when both HSF and 
DEX were present simultaneously.  The fibrinogen mRNA 
levels in the presence of DEX alone or HSF alone increases 
in comparison to the control fibrinogen mRNA levels, al- 
though to a much less extent ,x,l.5-3-fold that of control. 
Experiments were carded out to determine if protein syn- 
thesis was a required step in the increase of fibrinogen cyto- 
plasmic mRNA. It is generally recognized that in certain cir- 
cumstances there is a requirement for new protein(s) to be 
made to bring about changes in cytoplasmic mRNA levels 
(29). Results presented in Fig. 4 b (A and B) are cytodot anal- 
yses after each cell type had been incubated for 2 h  in the 
presence of CHX (2 Ixg/ml) before the addition of DEX or 
HSE  The  cytodot pattern  depicting  levels  of fibrinogen 
mRNAs for the primary hepatocytes were basically the same 
as in control, however, the pattern for the FAZA cells were 
quite different. When protein synthesis was blocked in the 
FAZA cell the HSF/DEX stimulation of cytoplasmic levels 
of fibrinogen was inhibited. Tubulin mRNA was also probed 
under  each  condition and  the  results  showed that  it  was 
unaffected by DEX, HSE or a combination of the two and 
thus could serve as a suitable internal control. If the modula- 
tors, either individually or together, were acting to stimulate 
RNA levels in general (either transcriptionally or posttran- 
scriptionally) then tubulin mRNA levels should follow the 
same increases and/or decreases. 
Northern Gel Analysis 
The effects of CHX on fibrinogen mRNA levels in the two 
cell types was further assessed by Northern gel analysis (Fig. 
5).  Results shown in A indicate the typical response of the 
two modulators on fibrinogen mRNAs.  The effects of a 2-h 
preincubation of CHX before adding DEX,  HSF,  and the 
combination of  the two does not alter the fibrinogen response 
in primary hepatocytes, but it dramatically reduces the stim- 
ulating effect in the FAZA cell. The RNAs shown in B were 
taken from cells that had been in the presence of CHX for 
a total of 8 h (2 h preincubation before the addition of modu- 
lators, then an additional 6 h in their presence). C shows the 
i,~ 
;o;  ;o;  ;o;  ;s;  ;s;  ,d 
HSF (30 U) 
Figure 3. Effects of various steroids and HSF on fibrinogen  produc- 
tion. Primary hepatocytes were prepared as in Fig.  I.  Maximum 
stimulating concentrations of  the steroids were determined  in previ- 
ous studies and found to be near 10  -7 M  (data not shown).  Cells 
were treated with steroids either in the absence ([]) or presence (I) 
of 30 U/ml HSE Control, CON; dexamethasone, DEX; hydrocorti- 
sone, COR; corticosterone, COS; testosterone, TST; 17-1~-estradiol, 
ES2E 17-tt-hydroxyprogesterone,  PRG; aldosterone, ALD. 
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mRNA levels in primary hepatocytes and hepatoma veils 
(FAZA).  (a) Slot blots of cytoplasmic RNA taken from 
primary hepatoeytes and FAZA cells after 12 h exposure 
to DEX (10  -7 M) and/or HSF (20 U/ml for hepatocytes 
and 100 U/ml for FAZA). Fibrinogen and tubulin mRNAs 
were probed with nick-translated cDNAs for fibrinogen 
subunits and for tubulin, respectively. (b) Slot blots as de- 
scribed in a except the cells had been treated with 2 Ixg/ml 
CHX for 2 h before the addition of DE)[ or HSF. 0.1  I~g 
of RNA for slot blots was taken at the end of a 12-h incu- 
bation. 
results of a  Northern gel after the ceils had seen CHX for 
8 h. They were washed twice with media removing the an- 
tibiotic and then were incubated for an additional 6 h in the 
presence of the modulators. These findings demonstrate that 
the FAZA ceils are capable of responding to the modulator 
once the block in protein synthesis has been removed. These 
data provide additional information that protein synthesis is 
required to get the full stimulating effect of HSF in FAZA 
cells. 
Fibrinogen Gene Transcription as Measured by 
Nuclear Run-off Experiments 
To determine  if HSF is exerting its  stimulatory effect on 
fibrinogen at the level of gene transcription, we carried out 
gene run-off experiments in isolated nuclei after exposure 
to HSE  We had previously demonstrated by Northern gel 
analysis significant increases in fibrinogen mRNA occurred 
1.5 h after exposure to HSF (9). We carried out time-course 
experiments and  showed that  a  maximal radioactive label 
was incorporated by 2 h (data not shown). Primary hepato- 
cytes were exposed to HSE  DEX,  or both for 2  h  before 
isolating the nuclei. When the nuclei were incubated under 
conditions that permit gene transcription  to continue,  and 
then the labeled RNA was isolated and hybridized to im- 
mobilized fibrinogen cDNA, the results shown in Fig. 6 were 
obtained.  A  clear and dramatic increase in  nuclear  RNA 
(representing a 10-fold increase in transcription of the fibrin- 
ogen genes)  was evident when both DEX  and  HSF were 
present.  The increases in cytoplasmic mRNA levels there- 
fore can be accounted for entirely by the addition of newly 
transcribed messages to the cytoplasmic pool. It can also be 
seen that the HSF molecule appears to cause an increase (ap- 
proximately threefold) in transcription when not in the pres- 
ence of DEX. DEX by itself caused no detectable increase 
in fibrinogen mRNA synthesis. Taken together these results 
indicate that HSF is a potent modulator of fibrinogen tran- 
scription and DEX appears to enhance the transcriptional ac- 
tivity brought about by the HSE We also examined the nu- 
clear RNA for alterations in transcription of  other genes. The 
results of probing with a cDNA to antithrombin III (3) (not 
an acute phase-responding protein) indicate that the condi- 
tion leading to alteration in fibrinogen gene transcription was 
specific and not the result of altering cellular transcription 
in general. 
Discussion 
In this study we analyzed the regulation of fibrinogen pro- 
duction  (synthesis and secretion) after administration of a 
major acute-phase regulator protein (HSF) and a potent glu- 
cocorticoid-hormone analogue (DEX) in an attempt to begin 
to determine how these two modulators interact.  We used 
both a nontransformed primary cell and a transformed cell 
line to better evaluate the role that each modulator plays in 
the regulation of fibrinogen synthesis. 
The results obtained from these studies suggest that DEX 
may regulate fibrinogen synthesis at two levels in the biosyn- 
thetic pathway. In the presence of DEX alone the increased 
secretion of 2-3 x  above control with a minimal increase in 
the mRNA levels indicates an enhanced translational or post- 
translational process. How this enhancement occurs is not 
clear from the present study. A  second site of DEX action 
Figure 5. Northern gel analysis. (,4) 10 
~tg of  RNA extracted by hot phenol from 
confluent monolayers of primary hepa- 
tocyte and FAZA cells was subjected to 
electrophoresis  in  agarose,  transferred 
to nitrocellulose, and probed with nick- 
translated cDNAs to fibrinogen  BI3 chain. 
DEX concentration  was  10  -7 M;  HSF 
was 20 U/ml for primary or 100 U/rnl for 
FAZA cells. (B) RNA prepared as in A 
but from cells that had been treated with 
2 ~tg/ml CHX for 2 h before the addition of DEX and/or HSE RNA was extracted from cells 12 h after the addition of the DEX and/or 
HSE (C) RNA extracted as in A. Cells were treated with CHX as in B, but at the end of 6 h, the media was changed to remove CHX; 
cells were incubated for I h, the media was changed again; then HSF and DEX were added as in A. At the end of  an additional 6-h incubation 
the RNA was extracted and analyzed as in A. 
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sis performed on isolated primary  hepatocyte nuclei. Approxi- 
mately 5.0  x  107 ceils were incubated for 2 h in the presence of 
10  -7 M DEX or 20 U/ml HSF or both. Nuclei were isolated (2 ￿ 
107/assay) and transcription was permitted to continue for 15 min 
in the presence of [32p]  UTP. The labeled RNA O.0  ￿  107 cpm) 
was purified and allowed to hybridize to the nitrocellulose  to which 
Act, B[3, and 7 fibrinogen cDNAs and antithrombin-lIl cDNA had 
been bound. The nitrocellulose was extensively washed and ex- 
posed to fibrin as described previously. 
is at the gene level since maximal transcription, as measured 
by nuclear run-off  studies, only occurs when DEX is present. 
The fact that steroids other than those with recognized gluco- 
corticoid activity do not affect the HSF signal reinforces 
the observation by Fowlkes et al.  (8),  who demonstrated 
the presence of  putative glucocorticoid receptor-binding se- 
quences  in  the  5'  nontranslational  regions  of the  three 
fibrinogen genes. These are potential steroid promoter sites 
where the glucocorticoid receptors may be binding and af- 
fecting HSF-stimulated transcription. 
Our findings from nuclear run-off studies provide strong 
evidence that the HSF signal acts exclusively at the level 
of gene transcription.  We believe these  are the first and 
most direct studies demonstrating that HSF controls fibrino- 
gen production by regulating the transcription of fibrinogen 
mRNAs. Our findings show that all three genes are being 
transcribed simultaneously since we detect the same amount 
of radioacEve label incorporated in each mRNA. Further- 
more, our studies show that DEX is not an essential compo- 
nent of the HSF-stirnulated transcription although it does 
synergistically  enhance the HSF effect. When both DEX and 
HSF are present, a  10-fold increase in transcription occurs. 
The lack of any significant amplification at later steps in the 
biosynthetic pathway indicates that HSF operates exclusively 
at the level of gene transcription. 
Baumann et al. (1) showed that in cultured rat hepatocytes 
the DEX-mediated induction of ~t~ acid glycoprotein is de- 
pendent on protein  synthesis. The findings reported here 
(Figs. 4 and 5) for the primary hepatocyte indicates that the 
fibrinogen response to HSF operates independently of pro- 
tein synthesis. The slight reduction in hybridizable mRNAs 
can be accounted for by the cytotoxicity that CHX would 
have on cells in the 12-h exposure time of the experiment. 
In FAZA cells, however, the HSF induction was completely 
blocked in the presence of CHX. This finding suggests that 
the DEX  enhancement requires  a  protein intermediate, a 
finding not unlike that of a~ acid glycoprotein (27). 6 haf- 
ter CHX was removed from the FAZA cells, a full induction 
could be achieved indicating that the cells could recover from 
the metabolic block and thereby reinforcing the finding that 
protein synthesis is required in the FAZA cells for them to 
be able to respond to the HSF signal. 
In summary, we have provided evidence that maximal 
stimulation of fibrinogen biosynthesis requires both a gluco- 
corticoid and the polypeptide HSE We have been able to sep- 
arate the interaction between these two modulators and show 
that HSF is exclusively a transcriptional regulator and DEX 
acts primarily by enhancing the HSF signal. We also show 
that there are some differences in the way DEX and HSF 
regulate fibrinogen in normal and transformed cells. For ex- 
ample, the requirement that several times more HSF is re- 
quired by FAZA cells to bring about a  ft~ fibrinogen re- 
sponse  as well as  some of the requirements for ongoing 
protein  synthesis indicates there are  some fundamentally 
different steps in the HSF signaling. We therefore raise a 
note of  caution in predicting regulatory pathways where only 
one type of  cells is used as the model system. Finally, we pre- 
dict that several acute-phase genes will contain common se- 
quence elements in their control regions which will be regu- 
lated by HSF and DEX in a manner analogous to fibrinogen. 
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